Stifel Financial
CBAY

Stifel Financial’s Cymabay Therapeutics CBAY Stock Holding History

Stifel Financial’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,500
Closed -$179K – 3066
2019
Q1 		$179K Buy
13,500
+1,500
+13% +$16K ﹤0.01% 2617
2018
Q4 		$96K Sell
12,000
-3,500
-23% -$33.3K ﹤0.01% 2566
2018
Q3 		$172K Hold
15,500
– – ﹤0.01% 2617
2018
Q2 		$207K Sell
15,500
-7,500
-33% -$93.9K ﹤0.01% 2535
2018
Q1 		$297K Buy
+23,000
New +$286K ﹤0.01% 2261

Other funds holding CBAY

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return